Torriglia A, Perani P, Brossas J Y, Altairac S, Zeggai S, Martin E, Tréton J, Courtois Y, Counis M F
Unité 450 INSERM, Association Claude Bernard, 75016 Paris, France.
Ann N Y Acad Sci. 2000;926:192-203. doi: 10.1111/j.1749-6632.2000.tb05612.x.
The discovery of caspase-mitochondrial pathway counts as one of the most important discovery in apoptosis biochemistry. Today, however, we begin to recognize its limits. Inhibition of caspase does not prevent cell death in many mammalian models. Targeted disruption of caspases does not impair every type of apoptosis. Other pathways, caspase independent, are now described. Here we present one of these pathways. It is a serine-protease dependent pathway and its key event is the transformation of LEI (a serine protease inhibitor) into L-DNase II (an endonuclease). When using this apoptotic pathway the cell activates, at the same time, its endonuclease activity (L-DNase II appears) and its protease activity (there is a release of inhibition of proteases).
半胱天冬酶-线粒体途径的发现堪称凋亡生物化学领域最重要的发现之一。然而如今,我们开始认识到其局限性。在许多哺乳动物模型中,抑制半胱天冬酶并不能阻止细胞死亡。对半胱天冬酶进行靶向破坏并不会损害每种类型的细胞凋亡。现在已描述了其他不依赖半胱天冬酶的途径。在此我们介绍其中一条途径。它是一条依赖丝氨酸蛋白酶的途径,其关键事件是LEI(一种丝氨酸蛋白酶抑制剂)转化为L-DNase II(一种核酸内切酶)。当细胞使用这种凋亡途径时,会同时激活其核酸内切酶活性(出现L-DNase II)和蛋白酶活性(蛋白酶抑制作用被解除)。